Back

Effect of Social Media Constraints on Mental Health: A Systematic Review and Meta-Analysis of Experiments

Lopes, M. V. V.; Branje, K.; David, A.; Gennara, A.; Haidt, J.; Rausch, Z.; Greb, N.; Aslam, A.; Lebwohl, J.; Chaput, J.-P.; Goldfield, G. S.

2026-06-02 psychiatry and clinical psychology
10.64898/2026.06.01.26354614 medRxiv
Show abstract

Background: Observational studies have consistently reported associations between social media use (SMU) and poorer mental health outcomes; however, such designs cannot establish causality. This study synthesised evidence from randomized experiments to estimate the effects of restricting SMU on mental health outcomes. Methods: A systematic search was conducted across MEDLINE, Embase, PsycINFO, and Cochrane CENTRAL to identify experimental trials evaluating interventions that constrained SMU for at least 24 hours and included an unconstrained control condition. Multilevel random-effects meta-analyses were used to synthesise effect estimates. Prespecified meta-regressions explored study-level moderators, and population-level impact fractions were estimated relative to global SMU prevalence. Results: From 7,784 screened records, 37 reports representing 35 distinct studies were included (pooled N = 7,160). Most interventions lasted one to three weeks and targeted college-aged youth. Pooled estimates favoured SMU constraints across outcomes, with magnitude and precision varying by domain. Confidence intervals were entirely above zero, consistent with a beneficial response for depressive symptoms (g = 0.22; 95% CI, 0.12 to 0.32), perceived stress (g = 0.15; 95% CI, 0.01 to 0.29), anxiety symptoms (g = 0.19; 95% CI, 0.05 to 0.34), fear of missing out/nomophobia (g = 0.14; 95% CI, 0.04 to 0.24), and well-being (g = 0.36; 95% CI, 0.10 to 0.63). Heterogeneity was substantial for several outcomes (I2 > 75%). In bivariate meta-regressions, higher baseline SMU was associated with larger effects for anxiety symptoms ({beta} = 0.13; 95% CI, 0.03 to 0.22), and longer interventions were associated with larger effects for depressive symptoms ({beta} = 0.16; 95% CI, 0.02 to 0.30). Inferences revealed that a short-term reduction in SMU globally could plausibly mitigate 17.5% and 15.4% of depressive and anxiety symptom cases, respectively. Conclusions: Experimental design-based evidence supports the causal case for an effect of SMU on mental health, with constraints producing improvements across multiple outcomes and no evidence of harm. Population-level inferences suggest that even individually modest effects may translate into meaningful public health benefits given the high prevalence of SMU exposure. These findings suggest that reducing SMU may represent a low-intensity, low-cost, scalable strategy to support mental health and improve well-being.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Psychological Medicine
74 papers in training set
Top 0.1%
18.4%
2
JAMA Network Open
127 papers in training set
Top 0.3%
8.3%
3
PLOS Medicine
98 papers in training set
Top 0.3%
7.1%
4
Journal of Affective Disorders
81 papers in training set
Top 0.3%
7.1%
5
PLOS ONE
4510 papers in training set
Top 25%
6.7%
6
BMJ Mental Health
15 papers in training set
Top 0.1%
4.2%
50% of probability mass above
7
Social Science & Medicine
15 papers in training set
Top 0.2%
3.9%
8
European Psychiatry
10 papers in training set
Top 0.2%
2.8%
9
Social Psychiatry and Psychiatric Epidemiology
11 papers in training set
Top 0.2%
2.7%
10
BJPsych Open
25 papers in training set
Top 0.2%
2.6%
11
Epidemiology and Psychiatric Sciences
10 papers in training set
Top 0.1%
2.4%
12
The British Journal of Psychiatry
21 papers in training set
Top 0.4%
2.3%
13
Frontiers in Psychiatry
83 papers in training set
Top 2%
2.0%
14
Journal of Medical Internet Research
85 papers in training set
Top 2%
1.9%
15
Scientific Reports
3102 papers in training set
Top 59%
1.7%
16
BMC Medicine
163 papers in training set
Top 5%
1.3%
17
Brain, Behavior, and Immunity
105 papers in training set
Top 2%
1.3%
18
Neuroscience & Biobehavioral Reviews
43 papers in training set
Top 0.6%
1.2%
19
eClinicalMedicine
55 papers in training set
Top 1%
1.2%
20
European Child & Adolescent Psychiatry
14 papers in training set
Top 0.3%
1.2%
21
Neuropsychopharmacology
134 papers in training set
Top 2%
0.9%
22
Nature Communications
4913 papers in training set
Top 62%
0.8%
23
BMJ Open
554 papers in training set
Top 13%
0.7%
24
Nature Human Behaviour
85 papers in training set
Top 5%
0.7%
25
European Neuropsychopharmacology
15 papers in training set
Top 0.7%
0.7%
26
BMC Psychiatry
22 papers in training set
Top 0.8%
0.7%
27
Molecular Psychiatry
242 papers in training set
Top 4%
0.7%
28
American Journal of Epidemiology
57 papers in training set
Top 2%
0.6%
29
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
62 papers in training set
Top 2%
0.6%
30
Journal of Epidemiology and Community Health
32 papers in training set
Top 0.8%
0.6%